Genetic Modification of Cancer Cells Using Non-Viral, Episomal S/MAR Vectors for In Vivo Tumour Modelling

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Argyros, Orestis ^a   Wong, Suet Ping ^a   Gowers, Kate ^a   Harbottle, Richard Paul ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PLASMID DNA; PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM COLONY; BIOLUMINESCENCE; CANCER CELL; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA MODIFICATION; EPISOME; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CELL CARCINOMA; MATRIX ATTACHMENT REGION; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENE; TUMOR MODEL; UBIQUITINATION;

ANIMALS; BLOTTING, SOUTHERN; CELL LINE, TUMOR; DNA PRIMERS; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDIES; LUCIFERASES; MATRIX ATTACHMENT REGIONS; MICE; MICE, SCID; PLASMIDS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UBIQUITIN C;

AGOUTI PACA; ANIMALIA; MUS;

EID: 84868128341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047920     Document Type: Article

References (31)

1. Jenkins DE, Oei Y, Hornig YS, Yu SF, Dusich J, et al. (2003) Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clinical & experimental metastasis 20: 733-744.
2. Kerbel RS, (1998) What is the optimal rodent model for anti-tumor drug testing?. Cancer metastasis reviews 17: 301-304.
3. Killion JJ, Radinsky R, Fidler IJ, (1998) Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer metastasis reviews 17: 279-284.
4. Wetterwald A, van der Pluijm G, Que I, Sijmons B, Buijs J, et al. (2002) Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. The American journal of pathology.
5. Stell A, Biserni A, Della Torre S, Rando G, et al. (2007) Cancer modeling: modern imaging applications in the generation of novel animal model systems to study cancer progression and therapy. The international journal of biochemistry & cell biology 39: 1288-1296.
6. Edinger M, Sweeney TJ, Tucker AA, Olomu AB, Negrin RS, et al. (1999) Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1: 303-310.
7. Aboody-Guterman KS, Pechan PA, Rainov NG, Sena-Esteves M, Jacobs A, et al. (1997) Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo. Neuroreport 8: 3801-3808.
8. Yang M, Baranov E, Jiang P, Sun FX, Li XM, et al. (2000) Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proceedings of the National Academy of Sciences of the United States of America 97: 1206-1211.
9. Dikmen ZG, Gellert GC, Dogan P, Yoon H, Lee YB, et al. (2008) In vivo and in vitro effects of a HIF-1alpha inhibitor, RX-0047. Journal of cellular biochemistry 104: 985-994.
10. Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, et al. (2007) Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. Journal of neurosurgery 107: 610-616.
11. Argyros O, Wong SP, Niceta M, Waddington SN, Howe SJ, et al. (2008) Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector. Gene Ther 15: 1593-1605.
12. Wang Y, Sun Z, Peng J, Zhan L, (2007) Bioluminescent imaging of hepatocellular carcinoma in live mice. Biotechnology letters 29: 1665-1670.
13. Zeamari S, Rumping G, Floot B, Lyons S, Stewart FA, (2004) In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats. British Journal of Cancer 90: 1259-1264.
14. Wilber A, Frandsen JL, Wangensteen KJ, Ekker SC, Wang X, et al. (2005) Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. Hum Gene Ther 16: 1325-1332.
15. Herweijer H, Zhang G, Subbotin VM, Budker V, Williams P, et al. (2001) Time course of gene expression after plasmid DNA gene transfer to the liver. The journal of gene medicine 3: 280-291.
16. Brooks AR, Harkins RN, Wang P, Qian HS, Liu P, et al. (2004) Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J Gene Med 6: 395-404.
17. Hong K, Sherley J, Lauffenburger DA, (2001) Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector. Biomolecular engineering 18: 185-192.
18. Piechaczek C, Fetzer C, Baiker A, Bode J, Lipps HJ, (1999) A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res 27: 426-428.
19. Jenke AC, Stehle IM, Herrmann F, Eisenberger T, Baiker A, et al. (2004) Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. Proc Natl Acad Sci U S A 101: 11322-11327.
20. Argyros O, Wong SP, Fedonidis C, Tolmachov O, Waddington SW, et al. (2011) Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver. Journal of Molecular Medicince 89: 515-529.
21. Wong SP, Argyros O, Coutelle C, Harbottle RP, (2011) Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage. Gene Ther 18: 82-87.
22. Argyros O, Wong SP, Harbottle RP, (2011) Non-viral episomal modification of cells using S/MAR elements. Expert Opin. Biol. Ther. 11: 1177-1191.
23. Jenke AC, Scinteie MF, Stehle IM, Lipps HJ, (2004) Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation. Mol Biol Rep 31: 85-90.
24. Lufino MM, Manservigi R, Wade-Martins R, (2007) An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. Nucleic Acids Res 35: e98.
25. Stehle IM, Postberg J, Rupprecht S, Cremer T, Jackson DA, et al. (2007) Establishment and mitotic stability of an extra-chromosomal mammalian replicon. BMC Cell Biol 8: 33.
26. Jenke BH, Fetzer CP, Stehle IM, Jonsson F, Fackelmayer FO, et al. (2002) An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo. EMBO Rep 3: 349-354.
27. Schaarschmidt D, Baltin J, Stehle IM, Lipps HJ, Knippers R, (2004) An episomal mammalian replicon: sequence-independent binding of the origin recognition complex. EMBO J 23: 191-201.
28. Papapetrou EP, Ziros PG, Micheva ID, Zoumbos NC, Athanassiadou A, (2006) Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element. Gene Ther 13: 40-51.
29. Jackson DA, Juranek S, Lipps HJ, (2006) Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol Ther 14: 613-626.
30. Lau WY, Lai EC, (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary & pancreatic diseases international: HBPD INT 7: 237-257.
31. Hidalgo M, (2010) Pancreatic Cancer. New England Journal of Medicine 362: 1605-1617.